(Q57942341)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098611%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

title

The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098611%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098611%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

Duncan Hannant

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098611%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

author name string

William Henley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098611%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

C F Crouch

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098611%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

J Wilkins

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098611%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

M J Francis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098611%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

publication date

10 August 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098611%20AND%20SRC:MED&resulttype=core&format=json

Veterinary Immunology and Immunopathology

5 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098611%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

volume

108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098611%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098611%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

345-355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098611%20AND%20SRC:MED&resulttype=core&format=json

Nasal delivery of vaccines

5 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

ISCOMs and other saponin based adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Immunopotentiation of local and systemic humoral immune responses by ISCOMs, liposomes and FCA: role in protection against influenza A in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Intranasal immunization of mice with Echinococcus granulosus surface antigens iscoms evokes a strong immune response, biased towards glucidic epitopes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

A mucosal IgA response, but no systemic antibody response, is evoked by intranasal immunisation of dogs with Echinococcus granulosus surface antigens iscoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Adjuvants--a classification and review of their modes of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Vaccines and mucosal immunisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Mechanisms of vaccine adjuvanticity at mucosal surfaces.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Mucosal immunity: implications for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Immunity to influenza A virus infection in young children: a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Cellular immune responses in the murine lung to local immunization with influenza A virus glycoproteins in micelles and immunostimulatory complexes (iscoms).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Improvement of the systemic prime/oral boost strategy for systemic and local responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Immune responses and side effects of five different oil-based adjuvants in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

The serum antibody response distributed in subclasses and isotypes after intranasal and subcutaneous immunization with influenza virus immunostimulating complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Summary report of the Second Equine Leucocyte Antigen Workshop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

The mucosal immune system: from fundamental concepts to vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

The ISCOM: an immunostimulating complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Protection against experimental infection with influenza virus A/equine/Miami/63 (H3N8) provided by inactivated whole virus vaccines containing homologous virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Duration of protective efficacy of equine influenza immunostimulating complex/tetanus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Antigenicity and immunogenicity of experimental equine influenza ISCOM vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Local and systemic isotype-specific antibody responses to equine influenza virus infection versus conventional vaccination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Equine influenza in vaccinated horses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Heterosubtypic immunity to influenza A virus infection requires B cells but not CD8+ cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Vaccination strategies for mucosal immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Immunity to experimental cholera. III. Enhanced duration of protection after sequential parenteral-oral administration of toxoid to dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Intranasal immunisation with influenza-ISCOM induces strong mucosal as well as systemic antibody and cytotoxic T-lymphocyte responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Efficacy of a cold-adapted, intranasal, equine influenza vaccine: challenge trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Diagnostic methods applied to analysis of an outbreak of equine influenza in a riding school in which vaccine failure occurred

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Studies with inactivated equine influenza vaccine: 1. Serological responses of ponies to graded doses of vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2005.06.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VETIMM.2005.06.009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16098611%20AND%20SRC:MED&resulttype=core&format=json

5 January 2020

1 reference